Bemfivastatin hemicalcium

Overview

Bemfivastatin (PPD 10558) hemicalcium is an orally active HMG-CoA Reductase ( HMGCR ) inhibitor. Bemfivastatin hemicalcium enhances the activity of liver extraction and reduces blood lipid levels. Bemfivastatin hemicalcium can be used for research of metabolic disease , such as hypercholesterolemia.

Application

Products | Products > Disease Areas > Metabolic or Endocrine Disease | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Research Areas > Metabolic Disease | Products > Signaling Pathways > HMG-CoA Reductase (HMGCR)

Product Information

• Catalog No.: HY-106281A
• CAS No.: 805241-64-9
• Molecular Formula: C34H37FN2O6.1/2Ca
• Molecular Weight: 607.74
• Purity: 98.00%
• Storage: 4°C, sealed storage, away from moisture and light * In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light)
• Availability: In-stock

Source

Original product source